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Laminin-1, a heterotrimer of a1, b1, and g1 chains speciﬁc to basement membrane, promotes cell adhesion and migration,
proteinase secretion and metastases of tumour cells. Several active sites on the a1 chain have been found to promote B16–
F10 melanoma lung colonisation and here we have determined whether additional tumour promoting sites exist on the b1
and g1 chains. Recently, we have identiﬁed novel cell adhesive peptides derived from laminin b1 and g1 chains by systematic
screening of synthetic peptides. Nine b1 peptides and seven g1 peptides active for cell adhesion were tested for their effects
on experimental pulmonary metastases of B16–F10 mouse melanoma cells in vivo. The most active adhesive peptide derived
from the g1 chain globular domain, C-16 (KAFDITYVRLKF), signiﬁcantly enhanced pulmonary metastases of B16–F10 cells,
whereas no other peptides showed enhancement. C-16 also stimulated migration of B16–F10 cells in the Boyden chamber
assay in vitro. Furthermore, C-16 signiﬁcantly induced the production of MMP-9 from B16–F10 cells. These results suggest that
this speciﬁc laminin g1 chain peptide has a metastasis-promoting activity and might be a new molecular target of anti-cancer
treatment.
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Laminin-1 is part of a family of glycoproteins speciﬁc to basement
membrane. It has multiple biological activities including promoting
cell adhesion, migration, differentiation, neurite outgrowth and
tumour cell malignancy (Timpl et al, 1979; Kleinman et al, 1985;
Martin and Timpl, 1987; Timpl, 1989). Laminin-1 enhances the
metastatic phenotype of tumour cells (Terranova et al, 1982,
1984; Barsky et al, 1984). In addition, laminin-1 induces produc-
tion of collagenase IV (Turpeenniemi-Hujanen et al, 1986),
urokinase-type plasminogen activator, and the 92-kDa matrix
metalloproteinase (MMP-9) (Khan and Falcone, 1997) in vitro.
Several biologically active sites on mouse laminin-1 that affect
tumour cells have been previously identiﬁed using synthetic
peptides (Yamada and Kleinman, 1992). YIGSR on the b1 chain
promotes tumour cell adhesion and migration (Graf et al,
1987a,b; Iwamoto et al, 1988) and inhibits experimental pulmonary
metastases of mouse melanoma cells and angiogenesis (Iwamoto et
al, 1987; Sakamoto et al, 1991). IKVAV on the a1 chain promotes
cell adhesion, tumour growth, angiogenesis, collagenase IV activity
by tumour cells, and experimental metastases as well as plasmino-
gen activator activation (Grant et al, 1989; Tashiro et al, 1989;
Kanemoto et al, 1990; Stack et al, 1991; Nomizu et al, 1992).
Recently, we have systematically screened a large set of over-
lapping synthetic peptides covering the whole mouse laminin-1
for their cell adhesive activities. Five peptides from the G-domain
of a1 chain (Nomizu et al, 1995), 12 peptides from the g1 chain
(Nomizu et al, 1997), 21 peptides from the short and long arms
of a1 chain (Nomizu et al, 1998), and 12 peptides from the b1
chain (Nomizu et al, 2000) were found to have signiﬁcant cell
adhesive activity. In addition, several peptides from the lami-
nin-1 have been identiﬁed to be active for angiogenesis
(Malinda et al, 1999; Ponce et al, 1999), acinar formation of sali-
vary gland (Hoffman et al, 1998), and neurite outgrowth (Powell
et al, 2000).
We previously identiﬁed several laminin a1 peptides that inﬂu-
ence the metastatic activities of B16–F10 melanoma cells. AG-73
peptide from the a1 G-domain causes liver metastases (Kim et
al, 1998), A-13 peptide from the N-terminal globule promotes an
increase in pulmonary metastases (Kuratomi et al, 1999), and the
AG-73 peptide (LQVQLSIR) promotes increased lung colonies
and liver metastases. Here we report effects of adhesive peptides
from the b1 and g1 chains on experimental pulmonary metastases
of B16–F10 cells in vivo. We have screened other adhesive peptides
from b1 and g1 chains for metastatic activity. We found that one
of the peptides derived from the short arm of g1 chain, C-16
(KAFDITYVRLKF), signiﬁcantly enhanced pulmonary metastases
of B16–F10 cells. This peptide also stimulated the migration of
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
s
Received 10 September 2001; revised 8 January 2002; accepted 10 January
2002
*Correspondence: Y Kuratomi, Department of Otorhinolaryngology,
Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka
812-8582, Japan; E-mail: kuratomi@qent.med.kyushu-u.ac.jp
British Journal of Cancer (2002) 86, 1169–1173
ã 2002 Cancer Research UK All rights reserved 0007–0920/02 $25.00
www.bjcancer.comB16–F10 cells in the Boyden chamber assay. In addition, C-16
signiﬁcantly induced production of MMP-9 by B16–F10 cells.
MATERIALS AND METHODS
Preparation of synthetic peptides
Cell adhesive peptides from the laminin b1 and g1 chain and
control peptides were synthesised and puriﬁed by high perfor-
mance liquid chromatography as previously described (Nomizu et
al, 1997). The purity and identity of the peptides were conﬁrmed
by an analytical HPLC and a Sciex API IIIE triple quadruple ion
spray mass spectrometer.
Cells and culture
B16–F10 mouse melanoma cells (Fidler and Nicolson, 1976) (a gift
of Dr IJ Fidler, Houston, TX, USA) were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Life Technologies, Inc.)
containing 10% foetal bovine serum (FBS; Hyclone, UT, USA),
100 units ml
71 penicillin, 100 mgm l
71 streptomycin (Life Tech-
nologies, Inc.).
In vivo experimental pulmonary metastasis assay
For the in vivo experimental pulmonary metastasis assay, B16–F10
cells were detached by 0.02% EDTA in phosphate buffered saline
(Versene, Life Technologies, Inc.) and suspended in DMEM
(1000000 cells ml
71). The cell suspension (0.2 ml) was injected
into the tail veins of female C57BL6/N mice (9–12 weeks old).
0.2 mg of cell adhesion peptides (1 mg ml
71 in DMEM) was also
intravenously injected within 10 min after the cell injection to
exclude cell aggregations by mixture of peptide and cells. The mice
were sacriﬁced 16 days after injection. The lungs were removed,
and the number of visible colonies on the surface of the lungs
was counted. When many colonies were formed and the number
of the colonies could not be counted correctly because of the
fusion of the colonies, the number was scored as 500. Five mice
were used for each peptide. Duplicate experiments gave similar
results.
All animals were maintained in ﬁlter top micro isolator cages
and provided with sterile water and food under conditions comply-
ing with National Institute of Health (NIH) regulations. All
manipulations of experimental animals were conducted in a lami-
nar ﬂow hood using strictly controlled procedures adhering to the
UKCCCR Guidelines for the Welfare of Animals in Experimental
Neoplasia to minimise stress or suffering (UKCCCR, 1998).
In vitro migration assay
Migration of B16–F10 cells through polycarbonate ﬁlters was
assayed using 48 well chemotaxis chambers (modiﬁed Boyden
chamber, Neuro Probe, MD, USA) as described previously (Kura-
tomi et al, 1999). The lower wells of the chamber were loaded with
DMEM containing 0.1% bovine serum albumin (BSA, Sigma)
(DMEM/BSA) and 100 mgm l
71 of peptide. Versene-detached
B16–F10 cells (50000 cells per 50 ml in DMEM/BSA) were placed
in the upper wells. After a 5 h incubation, cells on the lower
surface of the ﬁlter were stained with Diff-Quik (Baxter, IL,
USA), and counted under a microscope. Each peptide was tested
in triplicate and each experiment was repeated at least twice.
Zymography
B16–F10 cells (2500000 cells) were plated onto 150 mm dishes
with complete media. After 24 h, the media were replaced with
serum-free DMEM containing various concentrations of peptides.
The conditioned media were collected after a 16 h incubation at
378Ci n5 %C O 2 and concentrated 50 times by using Centriprep
10 (Amicon). Equal aliquots of the conditioned media (20 ml per
lane) were electrophoresed on 10% polyacrylamide gels containing
0.2% gelatin. The gels were washed with 10 mM Tris-HCl (pH 7.4)
containing 2.5% Triton-X for 30 min, followed by two changes of
10 mM Tris-HCl (pH 7.4) for 30 min. After an overnight incuba-
tion in 50 mM Tris-HCl (pH 8.0) containing 5 mM CaCl2 and
1m M ZnCl2 at room temperature, Coomassie blue was added to
visualise the digested gelatin bands.
RESULTS
Effect of cell adhesive laminin b1 and g1 chain peptides on
experimental pulmonary metastasis of B16–F10 mouse
melanoma cells
Nine peptides active for cell adhesion from the mouse laminin b1
chain (Nomizu et al, 2000) and seven peptides from the g1 chain
(Nomizu et al, 1997) were tested for their effects on in vivo experi-
mental pulmonary metastases of B16–F10 mouse melanoma cells
(Table 1). In control experiments (without peptides), the average
of 163 metastatic colonies was formed on the surface of the lung
within 16 days after B16–F10 cells were injected into the mouse
tail vein (Table 2). Peptide C-16 (KAFDITYVRLKF) from the N-
terminal globular domain of the g1 chain signiﬁcantly enhanced
the number of B16–F10 lung colonies (average of 482 colonies,
Table 2 and Figure 1). No other peptides showed stimulation or
inhibition of pulmonary metastases of B16–F10 cells (data not
shown). A scrambled peptide of C-16, C-16T (FYAFKKITLVRD),
slightly increased the number of B16–F10 lung colonies (average
of 234 colonies with range from 90 to 345), but the difference
was not signiﬁcant (Table 2, Figure 1). These results suggested a
sequence-speciﬁc enhancement of in vivo pulmonary metastases
of B16–F10 cells by C-16.
In vitro cell migration
In order to study the mechanism of the enhancement of B16–F10
lung colonisation by C-16, we examined the activities of these 16
cell adhesive peptides for cell migration. Among the 16 cell adhe-
sive peptides, 8 peptides (B-32, 34, 62, 133, 160; C-16, 64, 68)
stimulated migration of B16–F10 cells, with C-16 having the
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Table 1 Cell adhesive laminin b1 and g1 chain peptides used in this study
Peptides Sequences Residues
b1 chain
B-20 HLIMTFKTFRPA 114–125
B-30 RIQNLLKITNLR 202–213
B-31 TNLRIKFVKLHT 210–221
B-32 KLHTLGDNLLDS 218–229
B-34 REKYYYAVYDMV 234–245
B-54 KRLVTGQR 461–468
B-62 GPGVVVVEROYI 544–555
B-133 DSITKYFQMSLE 1298–1309
B-160 VILQQSAADIAR 1538–1549
g1 chain
C-16 KAFDITYVRLKF 139–150
C-28 TDIRVTLNRLNTF 245–257
C-35 LPFFNDRPWRRAT 318–330
C-57 APVKFLGNQVLSY 559–571
C-59 SFSFRVDRRDTR 576–587
C-64 SETTVKYIFRLHE 615–627
C-68 TSIKIRGTYSER 650–661
Cell adhesive peptides were identiﬁed by systematic screening of overlapping
peptides covering the entire mouse laminin b1 (Nomizu et al, 2000) and g1 chains
(Nomizu et al, 1997).
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tory activity of C-16 seemed to be comparable to that of peptide A-
13 from the a1 chain which previously was shown to be highly
active (Nomizu et al, 1998; Kuratomi et al, 1999). A control
scrambled peptide, C-16T, showed no stimulatory activity of
B16–F10 cell migration.
Gelatin zymography
Because matrix metalloproteinases (MMPs) have been implicated
in the metastatic process of tumour cells, we measured MMP
production from B16–F10 cells in the gelatin zymography assays
(Figure 3). C-16 enhanced the production of MMP-9 (92 kDa gela-
tinase) in a dose-dependent manner. With 20 mgm l
71 of C-16,
MMP-9 production was increased by approximately eight-fold over
that observed with the untreated control. MMP-2 production was
not stimulated by C-16. No other cell adhesive peptides from the
b1 and g1 chains stimulated the production of MMPs (data not
shown).
DISCUSSION
Laminin-1 has been shown to promote the metastatic activity of
melanoma cells (Terranova et al, 1982, 1984). We previously
reported that several peptide sequences including RQVFQVAYIII-
KA (A-13), IKVAV, and LQVQLSIR (AG-73) from the laminin
a1 chain have such activity (Kanemoto et al, 1990; Kim et al,
1998; Kuratomi et al, 1999). In this report, we identiﬁed a new site,
C-16 (KAFDITYVRLKF), on the laminin g1 chain which promotes
lung colonisation of B16–F10 cells in an experimental pulmonary
metastasis model in mice.
C-16 enhanced B16–F10 colonization about three-fold
compared with control. C-16 appears to be the only site on the
g1 chain of laminin-1 active for lung colonisation and no site on
the b1 chain was found to have this activity. C-16-mediated metas-
tasis promoting activity is comparable to that of A-13 and IKVAV.
Since laminin-1 is a highly potent promoter of the malignant
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Table 2 Effect of C-16 and C-16T on experimental pulmonary
metastases by B16-F10 cells
Number of lung colonies per mouse
Treatment Mean Range
Control 163 105–220
C-16 481 445–500
C-16T 234 90–345
B16-F10 cells (200 000 cells per 0.2 ml) were intravenously injected, then either C-
16 (0.2 mg per 0.2 ml) or C-16T (0.2 mg per 0.2 ml) was injected in the other tail
vein within 10 min after cell injection. The number of visible colonies on the surface
of the lungs was counted after 16 days. Data represent the average and the range of
ﬁve mice. C-16 signiﬁcantly increased the number of lung colonies (P50.00001),
while C-16T showed no signiﬁcant difference (P50.28). Duplicate experiments gave
similar results. All other peptides listed in Table 1 did not increase lung colonisation.
Figure 1 Appearance of the lung colonies formed by B16–F10 cells.
Two hundred thousand cells per 0.2 ml were injected through the tail vein,
then 0.2 mg per 0.2 ml of C-16 or the scrambled peptide of C-16, C-16T,
was injected in the other tail vein within 10 min after the cell injection.
Lungs were resected 16 days after the cell injection, then ﬁxed in formalin,
and photographed. C-16 (B) signiﬁcantly promoted the formation of pul-
monary metastases whereas C-16T (C) showed no enhancement as com-
pared to control (A). Duplicate experiments gave similar results.
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Figure 2 Effect of cell adhesive laminin b1 and g1 chain peptides on
B16–F10 cell migration. Migration of B16–F10 cells through the ﬁlters
was assayed by using 48 well Boyden chambers. The upper chamber con-
tained 50000 cells and the lower chamber contained 100 mgm l
71 of pep-
tide. After a 5 h incubation, the number of cells that migrated in the centre
of each well was counted under the microscope. Data represent
mean+s.d. of triplicate wells. Duplicate experiments gave similar results.
*P50.05; **P50.01.
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have been identiﬁed.
The mechanism by which A-13 and C-16 increase lung colonisa-
tion is not known. Cells must adhere, migrate, invade (protease
activity), proliferate, and generate blood supply in order to form
a growing metastatic lesion. A-13 and C-16 have been found to
promote all of these activities except cell proliferation. The role
of A-13 and C-16 in angiogenesis in the metastatic lesion has
not been tested. We did not examine the vascularity of the lung
lesions and it is unlikely that A-13 and C-16 persists in the circula-
tion or tissue for very long after injection. These are small
molecules which are cleared very rapidly from the circulation.
We speculate that A-13 and C-16 may enhance lung metastases
by increasing the invasion activity of the cells.
Laminin-1 stimulates cell migration (Kleinman et al, 1985) and
laminin a1 peptides with metastasis-promoting activity also have
activity for the migration of B16–F10 cells (Kuratomi et al,
1999). We have shown here that ﬁve b1 peptides and three g1
peptides stimulated migration of B16–F10 cells, with C-16 being
most active and comparable to A-13. Thus, laminin-1 has multiple
active sites for cell migration, which may function cooperatively.
Matrix metalloproteinases have been thought to be critical in
tumour invasion and metastases as well as in angiogenesis (Liotta,
1986; Liotta et al, 1991; Kohn and Liotta, 1995). C-16 showed
strong stimulation of MMP-9 production by B16–F10 cells. The
IKVAV peptide from the laminin a1 chain also induces MMP-1
and MMP-9 production from human monocyte/macrophage
(Corcoran et al, 1995). AG-73 was also reported to stimulate
MMP-9 activity of B16–F10 cells at the concentration of
50 mgm l
71 (Kim et al, 1998). C-16 is more potent in inducing
MMP-9 production than AG-73. C-16 stimulated MMP-9 produc-
tion nearly eight-fold at a concentration of 2 mgm l
71. This high
activity of C-16 for MMP-9 production as well as for cell migration
may explain its potent metastasis-promoting activity.
Recently, expression of the g2 chain of laminin-5, an epithelial
cell–speciﬁc laminin, was predominantly detected at the invasive
front of cancer cells of the colon, pancreas, stomach and oesopha-
gus (Pyke et al, 1995; Soini et al, 1996; Sordat et al, 1998;
Koshikawa et al, 1999; Yamamoto et al, 2001). The laminin g2
chain has been suggested to play a key role in the progression of
human carcinomas. C-16 is located in the N-terminal globular
domain of the laminin g1 chain, and this domain is deleted in
the g2 chain. However, it is possible that the deleted N-terminal
globular domain is co-expressed with laminin g2 chain by the
proteolytic cleavage of the g2 chain and that the cleaved domain
induces migration and metastases of tumour cells in human
cancers. Indeed, Giannelli et al (1997) have reported that lami-
nin-5 becomes active for promoting cell migration when cleaved
by MMP-2. It is possible that these active fragments of laminin-1
promote cell migration when it is degraded similar to laminin-5.
Four novel active sites (IKVAV, AG-73, A-13 and C-16) on
mouse laminin-1 have been identiﬁed for B16–F10 cell adhesion,
migration, MMP secretion, and metastases in this report and in
previous studies (Figure 4) (Kanemoto et al, 1990; Kim et al,
1998; Kuratomi et al, 1999). Interestingly, A-13 and C-16 are in
homologous locations on their respective chains at the amino
termini, binding to the same receptors and have similar activity
(Ponce et al, 2001; and unpublished data). Of the 12 amino acids,
three amino acids are identical and ﬁve are conserved. Preservation
of sequences and activity suggest important functional sites. Degra-
dation of laminin chains may also be important in exposure of
these active sites. These active sites might be new molecular targets
of anti-cancer treatments which prevent distant metastases of
malignant tumours. Furthermore, speciﬁc antibodies to these sites
and inhibitory peptides might lead to development of therapeutic
agents for human malignant tumours.
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